The radioprotection of salivary glands by vitamin C and sodium bicarbonate in 131I treatment of patients with differentiated thyroid carcinoma

被引：0
|
作者：
Tong, Huimin [1 ]
Gao, Ying [1 ]
Zhang, Xiaomin [1 ]
Li, Xiaoqian [1 ]
Luo, Liping [1 ]
Huang, Nan [1 ]
Hu, Tingting [1 ]
An, Jie [1 ]
Wang, Jin [1 ]
Cheng, Yan [1 ]
机构：
[1] Shanxi Med Univ, First Hosp, Taiyuan, Peoples R China
来源：
JOURNAL OF NUCLEAR MEDICINE | 2021年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1696
引用
收藏
页数：6
相关论文
共 50 条
  • [21] Therapeutic safety evaluation of sodium glycididazole combined with 131I radiotherapy for differentiated thyroid carcinoma
    SUN Wenwei GU Xinquan# GAO Shi BAI Lin CUI Qu MA Qingjie Wang Qing Zhao Guoqing China-Japan Union Hospital
    NuclearScienceandTechniques, 2011, 22 (04) : 212 - 216
  • [22] Role of 131I in the treatment of well differentiated thyroid cancer
    Woodrum, DT
    Gauger, PG
    JOURNAL OF SURGICAL ONCOLOGY, 2005, 89 (03) : 114 - 121
  • [23] Low activity treatment with 131I in differentiated thyroid cancer
    Olivan-Sasot, P.
    Prado-Wohlwend, S.
    Sanchez-Vano, R.
    Yepes-Agudelo, A.
    Agudelo-Cifuentes, M.
    Bernal-Vergara, J.
    Bello-Arques, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S608 - S609
  • [24] Incremental Value of 131I SPECT/CT in the Management of Patients with Differentiated Thyroid Carcinoma
    Chen, Libo
    Luo, Quanyong
    Shen, Yan
    Yu, Yongli
    Yuan, Zhibin
    Lu, Hankui
    Zhu, Ruisen
    JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (12) : 1952 - 1957
  • [25] 131I SPECT/CT in the Follow-Up of Patients With Differentiated Thyroid Carcinoma
    Menges, Mareen
    Uder, Michael
    Kuwert, Torsten
    Schmidt, Daniela
    CLINICAL NUCLEAR MEDICINE, 2012, 37 (06) : 555 - 560
  • [26] Implications of mediastinal uptake of 131I with regard to surgery in patients with differentiated thyroid carcinoma
    Haveman, JW
    Phan, HTT
    Links, TP
    Jager, PL
    Plukker, JTM
    CANCER, 2005, 103 (01) : 59 - 67
  • [27] Bone Marrow Function After 131I Therapy in Patients With Differentiated Thyroid Carcinoma
    Prinsen, Hester T.
    Hesselink, Esther N. Klein
    Brouwers, Adrienne H.
    Plukker, John T. M.
    Sluiter, Wim J.
    van der Horst-Schrivers, Anouk N. A.
    van Imhoff, Gustaaf W.
    Links, Thera P.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (10): : 3911 - 3917
  • [28] Additional Value of 131I SPECT/CT in the Management of Patients with Differentiated Thyroid Carcinoma
    Marini, I.
    Maussier, M.
    Perotti, G.
    Salvatori, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S72 - S72
  • [29] Interrupted 131I Procedures for Patients With Differentiated Thyroid Cancer
    Karls, Shawn
    Abikhzer, Gad
    Tamilia, Michael
    Probst, Stephan
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (04) : 247 - 249
  • [30] Evaluation of the Efficiency of 131I Ablative Dose of Residual Thyroid Tissue in Patients with Differentiated Thyroid Carcinoma
    Ben Sellem, D.
    Kraiem, T.
    Letaief, B.
    Ben Slimene, M. F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S348 - S349
12345